Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe webpage has been updated with new clinical trial data regarding the pharmacokinetics of nivolumab, including details on maximum serum concentration (Cmax), time to reach Cmax (Tmax), and area under the concentration-time curve (AUC). Additionally, new reporting dates for results have been added.SummaryDifference73%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check41 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has updated to Revision v2.14.0, introducing a new 'Results Submitted' feature and changing the 'Type of intervention' terminology, while removing the previous 'No Results Posted' status from Revision v2.13.3.SummaryDifference0.4%
- Check92 days agoChange DetectedThe website has been updated to version 2.13.3, replacing the estimated last update posted in version 2.13.2.SummaryDifference0.1%
Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.